Navigation Links
New Drug Could Work Against Leukemia
Date:7/2/2009

Researchers see promise for treatment of AML and other cancers

THURSDAY, July 2 (HealthDay News) -- A new targeted therapy shows promise in treating acute myeloid leukemia, a highly treatment-resistant blood cancer, according to a new study.

Researchers created an antibody (7G3) that recognizes and binds to a molecule called CD123, which is expressed at high levels on leukemia stem cells (LSCs), but not on normal blood cells. LSCs are cells that can cause acute myeloid leukemia (AML) and are critical for its long-term growth.

When AML-LSCs from human patients were transplanted into mice, those treated with 7G3 survived longer than mice that didn't receive the antibody. The researchers found that 7G3 blocked a signaling pathway in tumor cells, impaired migration of AML-LSCs to bone marrow and activated the immune system to destroy AML-LSCs.

The findings, published in the July 2 issue of the journal Cell Stem Cell, hold promise for future cancer treatments, according to the study authors.

"The recent characterization of defined populations of cancer stem cells in a range of human malignancies, as well as their relative resistance to conventional chemotherapy and radiotherapy, supports the broad applicability of our approach and provides rationale for the progression of AML-LSC-targeted therapeutics from preclinical evaluation to clinical trials," wrote Richard Lock, an associate professor at the Children's Cancer Institute Australia and the University of New South Wales, in a news release.

More information

To learn more about AML, visit the National Cancer Institute.



-- Robert Preidt



SOURCE: Cell Press, news release, July 2, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Monthly Pet Pill Could Kill Fleas, Ticks
2. Measurements fail to identify TB patients who could benefit from shorter treatment course
3. Growing Proteomics Market and the Current Economic Crisis Could Act in Tandem to Spur Growth in the European 2 Dimensional Gel Electrophoresis Market, States Frost & Sullivan
4. Hormone Could Improve Diabetes Treatment
5. Cell Protein Could Help Spur Malignancy
6. Hundreds of Genes Could Be Linked to ADHD
7. Health-Care Reform Could Be Obamas Toughest Challenge
8. Hysterectomies Could Be Source of Stem Cells
9. ORNL finding could help electronics industry enter new phase
10. Wrong type of help from parents could worsen childs OCD
11. Report: Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Preventing Honest Disclosures
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Drug Could Work Against Leukemia
(Date:12/2/2016)... NY (PRWEB) , ... December 02, 2016 , ... More ... school and while 84 percent of parents report speaking with their child about sex ... and sexually transmitted diseases. , Mediaplanet is proud to announce the launch of its ...
(Date:12/2/2016)... ... 2016 , ... Sourced from the Isbre Springs beneath the 5,000 year old ... purity of just 6 ppm TDS (Total Dissolved Solids) in addition to its excellent ... in several ShopRite and FoodTown stores in NJ and received rave comments from consumers. ...
(Date:12/2/2016)... ... 02, 2016 , ... On November 24th, 2016, Thanksgiving morning, ... different sites throughout Miami-Dade and Broward counties. This is the largest meal delivery ... Thanksgiving morning by putting together individual meals via assembly lines and passing them ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... offer a comprehensive in-house dental plan for all patients. Understanding that budget can ... that gives patients a number of perks, including discounts on many valuable dental ...
(Date:11/30/2016)... Cambridge, MA (PRWEB) , ... November 30, 2016 ... ... care for treating injured workers have been a focus of public policymakers and ... Workers Compensation Research Institute (WCRI) released its Medical Price Index for Workers’ ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... - bioLytical lanza el INSTI HIV Self Test ... Continue Reading ... New: ... , , bioLytical Laboratories (la "Compañía"), ... está expandiendo el lanzamiento de su INSTI HIV Self Test  a África con ...
(Date:12/2/2016)... held the largest share in the ECG Cables And ... demand for remote monitoring ECG devices. On the other hand, ... to witness the highest growth rate during the forecast period. ... Dickinson and Company (U.S.), Medtronic plc ( Ireland ... and Mindray Medical International Limited ( China ), ...
(Date:12/2/2016)... 2016 Research and Markets has announced the ... and Demand Forecast to 2022" report to their offering. ... , , ... 2015, and it is expected to grow at a CAGR of 5.5% ... witness faster growth during the forecast period, a CAGR of 8.8% in ...
Breaking Medicine Technology: